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Abstract
  Bovine congestive heart failure (BCHF) has becomeBackground:
increasingly prevalent in feedlot cattle in the Western Great Plains of North
America. BCHF is an untreatable complex condition involving pulmonary
hypertension that culminates in right ventricular failure and death. A protein
variant of hypoxia-inducible factor 2 alpha (HIF2α, encoded by the
endothelial PAS domain-containing protein 1 gene,  ) was previouslyEPAS1
reported to be associated with pulmonary hypertension at altitudes
exceeding 2,000 m. Our aim was to evaluate   haplotypes forEPAS1
association with BCHF in feedlot cattle raised at moderate altitudes (1,200
m).
 Paired samples of clinical cases and unaffected controls wereMethods:
collected at four feedlots in Nebraska and Wyoming. Each pair (n =102)
was matched for source, pen, breed type, sex, arrival date, and
management conditions. Cases were identified by animal caretakers,
euthanized, and diagnosis was confirmed at necropsy. Cases were derived
from 30 different ranch operations, with the largest source contributing 32.
Animals were tested for eight   haplotypes encoding 36 possibleEPAS1
different diploid combinations.
 The common, ancestral   haplotype encoding HIF2α withResults: EPAS1
alanine (A) at position 606 and glycine (G) at position 610 was equally
frequent in cases and controls (0.67). The   variant haplotypeEPAS1
reported to be associated with disease (encoding threonine (T) at position
606 and serine (S) at position 610) was not enriched in cases compared
with controls (0.21 and 0.25, respectively). Frequencies of other EPAS1
haplotypes (e.g., encoding Q270, L362, or G671) were each less than 0.05
overall. McNemar’s test with 45 discordant pairs showed the linked
T606/S610 variant was not associated with BCHF (OR = 0.73, CI  0.38
-1.4, -value = 0.37). p
 HIF2α polypeptide variants were not significantly associatedConclusions:
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  HIF2α polypeptide variants were not significantly associatedConclusions:
with BCHF in feedlot cattle at moderate altitudes. Thus, a wider search is
needed to identify genetic risk factors underlying this disease.
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Introduction
Brisket disease has been known in the Rocky Mountain 
Region of Colorado and Utah for more than 100 years as a 
high altitude disorder characterized by severe ventral edema of 
the chest tissues1,2. In affected cattle, the reduced partial 
pressure of oxygen at high altitudes causes pulmonary hypoxia, 
vascular resistance, arterial remodeling, and pulmonary hyper-
tension. As late as 1963, reports of brisket disease were lim-
ited to cattle grazed at altitudes greater than 2,100 m, with a 
prevalence of 2–10%3. This condition, attributed to ‘cor pulmo-
nale’, eventually causes right ventricular overload and enlarge-
ment, ultimately leading to heart failure. In 1976, a similar 
condition was reported in yearling feedlot cattle maintained at a 
lower altitude of 1,600 m4. Since the 1970’s, bovine congestive 
heart failure (BCHF) has become increasingly common in feedlot 
cattle maintained at the low to moderate altitudes of the North 
American Plains (800 to 1,600 m)5. However, it is uncertain 
whether hypobaric hypoxia is the underlying cause of BCHF 
in these cattle, and evidence suggests that left heart dysfunc-
tion may initiate BCHF6. Histopathological assessment of car-
diopulmonary tissues obtained from affected cattle fattened at 
544–1,420 m revealed significant ventricular fibrosis, abundant 
cardiac adipose depots, coronary artery injury, and pulmonary 
venous remodeling6. These features were phenotypically dis-
tinct from those of cattle with cor pulmonale at high altitudes. 
However, other evidence in similarly affected cattle (1,369 m) 
suggested death occurred prior to the development of advanced 
obesity7. Thus, disease pathogenesis of BCHF in feedlot cattle 
maintained at the moderate altitudes remains unclear.
The impact of BCHF on animal mortality is substantial and 
appears to be increasing. Mortality in the U.S. and Canada has 
been estimated at 11 per 10,000 animals entering feedlots, with 
the rate doubling from 2002 to 20125. Personal communica-
tion between authors (MPH and BLVL) and a Nebraska feedlot 
owner (G. Darnall) in 2018 indicated a BCHF prevalence as 
high as 7.5% in some single source lots of cattle. Affected cattle 
were typically bred and managed with the aim of achieving high 
carcass quality. For some affected producers in the Western 
Plains, BCHF is their single most costly health-related problem, 
with losses exceeding $250,000 annually in individual operations, 
surpassing those from bovine respiratory disease. Consequently, 
reducing the impact of BCHF is a high priority for the cattle 
industry.
A potential genetic risk factor for BCHF was reported in 2015 
for cattle with high-altitude pulmonary hypertension (1,478 to 
2,618 m)8. Angus cattle affected with pulmonary hypertension 
had a higher frequency of the endothelial PAS domain-containing 
protein 1 gene (EPAS1) encoding a hypoxia-inducible factor 2 
alpha (HIF2α) double variant with threonine (T) at position 606 
and serine (S) at 610. This HIF2α T606/S610 variant was pro-
posed to have a dominant gain-of-function activity8. Subsequent 
whole genome sequencing analysis of EPAS1 in 19 breeds of 
U.S. cattle identified four additional HIF2α variants encoded by 
EPAS1 (E270Q, P362L, A671G, and L701F)9. Together, these 
six amino acid variants comprised eight distinct polypeptide 
HIF2α sequences. A rooted phylogenetic tree of these HIF2α 
protein sequences provided a framework for evaluating their 
potential impact on BCHF in U.S. cattle9. In the present report, 
our aim was to evaluate EPAS1 haplotypes encoding HIF2α 
protein variants for association with BCHF in feedlot cattle, 
raised at moderate altitudes. Here we show that the HIF2α T606/
S610 variant encoded by EPAS1 was not associated with BCHF 
in feedlot cattle maintained at 1,200 m in the geographic region 
experiencing outbreaks. The results are important for understand-
ing the disease mechanism and for future selection of breeding 
animals with reduced risk for BCHF.
Methods
Ethical statement
The experimental design and procedures used during this 
research project were approved by the Institutional Animal Care 
and Use Committee (IACUC) of the University of Nebraska- 
Lincoln (UNL) Experimental Outline Number 139. The UNL 
animal care program is accredited by the Association for Assess-
ment and Accreditation of Laboratory Animal Care, registered 
with the United States Department of Agriculture, and assured 
by the National Institutes of Health Public Health Service Policy 
on Humane Care and Use of Laboratory Animals. The university 
meets these goals through review and approval by the IACUC 
before projects are initiated for any research and educational 
activities involving vertebrate animals, to assure compliance with all 
laws, regulations and rules governing the care and use of animals, 
and by continuing review and monitoring of approved studies. 
No animals were housed at research facilities or cared for by 
researchers during this study. All animals were privately owned 
and located at commercial feedlot operations and managed 
according to their standard operating procedures (SOP), 
which includes euthanasia of terminal heart failure cases as 
recommended by the American Veterinary Medical Association 
(AVMA). All pen matched unaffected (control) animals were 
briefly sampled by collecting an ear notch and blood sample 
and returned to their pens without further involvement in the 
study. In every instance, efforts were made to ameliorate animal 
suffering for this incurable, untreatable congesting heart disease.
Animals and study design
Paired samples from 102 affected calves and their 102 unaf-
fected matched penmate controls were collected from four 
private commercial feedlots during a 16-month period spanning 
January 2017 to April 2018. A sample size of 100 matched pairs 
was targeted based on the frequency of the EPAS1 T606/S610 
variant in Angus cattle (0.22)9. Together with Hardy-Weinberg 
assumptions, the proportion of discordant pairs having one or 
two copies of the dominant risk factor was expected to be 0.476 
and achieve greater than 80% power to detect an odds ratio of 2.5 
using a two-sided McNemar test with a significance level of 
0.05 (PASS 2019 Power Analysis and Sample Size Software, 
version 19.0.2 (NCSS, LLC. Kaysville, Utah, USA).
Potential clinical cases were identified by experienced animal 
caretakers on horseback (pen riders) and segregated for treat-
ment by moving to a hospital pen. This daily activity is part of the 
SOP for pen riders, i.e., to identify animals with any potentially 
serious health problems and move them to a dedicated treatment 
area. Terminal cases were euthanized by feedlot personnel based 
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on clinical presentation. Euthanasia was accomplished with 
a well-placed bullet by trained feedlot personnel according to 
AVMA approved protocols, as part of the feedlot operation’s SOP 
for terminally ill animals. The case definition included two or 
more clinical signs specific to BCHF: ventral and intermandibular 
edema (‘brisket’ and ‘bottle jaw’), jugular vein distention 
and pulsation, ascites/abdominal swelling, and exophthalmia 
(‘bug-eye’)10,11. The case definition also included two or more 
non-specific clinical signs: dyspnea, abducted elbows, depres-
sion, drooped ears, intermittent watery orange diarrhea, tachycar-
dia, exercise intolerance, open mouth breathing, and weight loss. 
Clinical signs increased with disease progression and in some 
cases, animals died naturally within 24 hours of clinical pres-
entation, while other cases progressed over a period of days to 
weeks, and thus provided a window of opportunity to collect 
fresh samples immediately after euthanasia. Researchers were 
contacted by the feedlot operator when an animal became ill and 
needed to be euthanized. Researchers then travelled to the feed-
lot for sample collection. A presumptive diagnosis based on 
heart morphology and gross lesions was made at necropsy by 
animal caretakers (cases one to nine) and veterinarians (cases 10 
to 102). Carcasses were enrolled in the study only if there was a 
postmortem presumptive diagnosis of congestive heart failure 
at necropsy.
Control tissue samples were collected from non-affected 
penmates matched for source, arrival date, gender, and breed type 
(based on source, coat color, horned/polled status, ear size and 
dewlap). The pen sizes ranged from 100 to 300 animals, and 
control animals were selected based on their willingness to be 
driven through the gate by riders on horseback. In two instances, 
the same control animal was inadvertently used as a penmate match 
for two clinical cases. None of the control animals developed 
clinical BCHF signs prior to harvest according to feedlot 
records and pen rider observations.
Tissue samples for genomic DNA isolation included V-shaped 
ear notches and EDTA whole blood collected by venipuncture. 
Squeeze chute devices at the feedlot facilities were used for 
sample collection with animals that were able to safely enter and 
exit the gates. Some affected animals were not able to safely enter 
the device and thus, their samples were collected immediately 
after euthanasia. The ear tissue was desiccated with granular 
NaCl in the field and stored at -20°C upon return to the research 
facility (four to twelve hours later). The plasma and cellular 
fractions of EDTA whole blood were separated in the field by 
centrifugation for 10 minutes at 1,350 x g, placed in liquid 
nitrogen immediately and stored at -80°C upon return. Hearts, 
livers, blood, and ear notches from unaffected cattle were 
collected during federally-inspected beef processing at the 
U.S. Meat Animal Research Center abattoir from six purebred 
Angus heifers raised and fattened at 578 m and 15 purebred 
Angus cows maintained for breeding at 578 m.
DNA extraction and single nucleotide polymorphism (SNP) 
genotyping
Unless otherwise indicated, reagents were molecular-biology 
grade. DNA from ear notches was extracted by standard 
procedures12. Briefly, hair follicles were shaved from the tissue 
and approximately one half of the ear notch was minced and sus-
pended in 2.5 mL of a lysis solution containing 10 mM TrisCl, 
400 mM NaCl, 2 mM EDTA, 1% wt/vol sodium dodecyl 
sulfate, RNase A (250 ug/ml; Sigma-Aldrich, St. Louis, Missouri, 
USA), pH 8.0. The solution was incubated at 55°C with gentle 
agitation. After one hour, 1 mg proteinase K was added (Sigma-
Aldrich) and the solution was incubated overnight at 55°C with 
continued agitation. The solution was transferred to a 15 ml 
tube containing 2 ml of a phase-separation gel (high-vacuum 
grease, Dow Corning Corporation, Midland, Michigan, USA) 
and extracted twice with one volume of phenol:chloroform:iso-
amyl alcohol (25:24:1), and once with one volume of chloroform 
before precipitation with two volumes of 100% ethanol. The pre-
cipitated DNA was washed once in 70% ethanol, briefly air dried, 
and dissolved in a solution of 10 mM TrisCl, 1 mM EDTA (TE, pH 
8.0). A single multiplex matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry (MALDI-TOF MS) assay was 
used for the six EPAS1 missense SNPs, as previously described9. 
Assay design and genotyping was performed at Neogen GeneSeek 
Operations (Lincoln, Nebraska, USA). The iPLEX Gold technol-
ogy and MassARRAY DNA analysis system with MALDI-TOF 
MS (Agena Biosciences Inc., San Diego, California) was used 
according to the manufacturer’s protocol. Briefly, genomic DNA 
was amplified in microtiter plates using the supplied reagents. 
After the PCR, excess nucleotides were dephosphorylated by 
shrimp alkaline phosphatase. This was followed by a single base 
extension reaction in which a mix of oligonucleotide extension 
primers was added together with an extension enzyme and mass-
modified dideoxynucleotide terminators. The extension prim-
ers are designed to anneal directly adjacent to each SNP site and 
were extended and terminated by a single complementary base. 
The extension products were desalted and transferred from the 
microtiter plate onto a chip array, where they crystalize with a 
pre-spotted MALDI matrix. The chip array was loaded into the 
mass spectrometer, where the analyte crystals were irradiated by 
a laser, inducing desorption and ionization. The positively charged 
molecules accelerate into a flight tube towards a detector. Sepa-
ration occurs by time-of-flight, which is proportional to the mass 
of the individual molecules. After each laser pulse, the detector 
records the relative time of flight for each extension product 
and the results were displayed on the machine. Genotypes were 
scored automatically and summary reports were generated.
Assigning haplotype phase and statistical analyses
As previously reported, a maximum parsimony phylogenetic 
tree was used to unambiguously phase protein variants encoded 
by EPAS1 haplotypes9. Haplotype-phased protein variants were 
unambiguously assigned in individuals that were either: 
1) homozygous for all six variant sites, or 2) had exactly one het-
erozygous variant site. The phylogenetic tree was also important 
for providing a framework for chi-squared testing. The associa-
tion of EPAS1 haplotype combinations (diplotypes) with clinical 
disease was evaluated with two tests. The first was a Pearson’s 
chi-squared test since it met requirements for appropriate use: 
nominal categorical data, large sample size (n = 204), and 
independence of observation assumption (cases were mutu-
ally exclusive of controls). There was a small deviation of the 
Page 4 of 12
F1000Research 2019, 8:1189 Last updated: 05 SEP 2019
assumption that each subject contributes to one and only one 
cell, because two of the control animals were each inadvertently 
drawn twice from their pen. None of the animals classified as 
controls developed clinical disease prior to harvest. A 2 x 4 
contingency table was used to test the four diplotypes combina-
tions represented by at least ten animals13. The second evaluation 
for association of the EPAS1 T610/S610 variant with clinical 
disease was McNemar’s test for correlated proportions14. This 
is the most appropriate test for paired nominal data.
Results
The 102 clinical BCHF cases and their penmate controls 
originated from 30 different sources, with the largest single source 
contributing 32 matched pairs (Table 1 and S1, see Underlying 
data). Although breed information was not available for many 
animals, the pairs were comprised of 100% polled, 93% solid 
black, and 70% male calves (Table S1, see Underlying data). 
Most of the 102 calves were from known, well-managed herds 
that focus on using Angus genetics. Clinical cases of BCHF were 
documented throughout all stages of calf fattening regimens 
(Figure 1). The most consistent signs at necropsy included: 
ventral and intermandibular edema, dilated pulmonary artery 
and right ventricle, and chronic passive congestion of the liver 
(Figure 2). The success of identifying BCHF cases was entirely 
dependent on highly trained, experienced pen riders. The false 
positive rate for pen rider-identified BCHF cases confirmed at 
necropsy was zero at sites NE01, NE04, and WY01; and 50% at 
WY02 (three cases from six suspected cases). Together, samples 
from the 102 matched case-control pairs represent a resource 
for evaluating genetic, biochemical, and physiological questions 
about the mechanism of BCHF in feedlot cattle.
DNA samples from cases and controls were tested for associa-
tion with known EPAS1 haplotypes according to the phylogenetic 
framework presented in Figure 3. Haplotype-phased protein 
variants (diplotypes) were unambiguously assigned for 98.5% of 
the animals (201/204, Table S1, see Underlying data). The fre-
quency of the common, ancestral EPAS1 haplotype (‘1’) was 
nearly identical in the cases and controls (0.67). The T606/S610 
variant reported to be dominantly associated with high-altitude 
pulmonary hypertension (haplotype ‘3’) was less frequent in the 
cases (0.21) than the controls (0.25, Table 2). In addition, there 
was no statistical difference between four common diplotypes 
among the cases and controls in a Pearson’s chi-square analy-
sis (Table 3). However, the appropriate statistical test for paired 
nominal data is McNemar’s test. This test with 45 discordant pairs 
showed the T606/S610 variant was not associated with BCHF 
(Table 4, OR = 0.73, p-value = 0.37, CI95 0.38 -1.4). With 0.44 
Table 1. Feedlot sites and sources for 
case-control pairs.
Sitea Altitude m (ft) Pairs Sources
NE01 1,242 (4,075) 76 19
NE04 1,163 (3,816) 17 9
WY01 1,263 (4,143) 6 1
WY02 1,280 (4,198) 3 1
Totals 102 30
aNE and WY sites were located in Nebraska and 
Wyoming, respectively
Figure 1. Bovine congestive heart failure (BCHF) clinical cases at different stages of fattening. Three types of animals identified by 
feedlot pen riders as end-stage heart failure candidates. Clinical cases were born and raised at 1,000 to 1,200 m prior to feedlot arrival. Their 
respective heart gross morphologies with enlarged right ventricles and pulmonary arteries are shown below each case. The control heart is 
from an Angus heifer fattened at 550 m.
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Figure 2. Gross morphological differences of a heart and liver 
in a representative bovine congestive heart failure (BCHF) 
clinical case. Panel A, affected heifer from (pair 77, Table S1) 
fattened at 1,200 m. Panel B, Gross heart morphology of affected 
heifer from pair 77 (left) and an unaffected Angus cow maintained 
for breeding at 578 m (right). The dashed line denotes where each 
heart was sectioned to show the dorsal half. Abbreviations: RV, right 
ventricle; LV, left ventricle; PA, pulmonary artery. Panel C, cross-
section of the respective livers.
Figure 3. Physical map and rooted maximum parsimony 
phylogenetic tree of HIF2α protein variants (EPAS1 haplotypes). 
Panel A, map of bovine HIF2α domains in relationship to missense 
mutations found in cattle: bHLH, basic helix-loop-helix domain; 
PAS-A and PAS-B, Per-Arnt-Sim domains; ODDD, oxygen-
dependent degradation domain; N-TAD, N-terminal transactivation 
domain; C-TAD, C-terminal transactivation domain. Panel B, HIF2α 
polypeptide sequences encoded by haplotype variants. The areas 
of the circles are proportional to the variant frequency in a group of 
1,250 cattle from 46 breeds with each node in the tree representing 
a different polypeptide sequence of HIF2α that varies by one 
amino acid compared to adjacent nodes. Reproduced from Heaton 
et al., 20169.
Table 2. EPAS1 haplotype frequencies among cases 
and controls.
Allele frequencies
Haplotype 
code
Distinguishing 
Feature
Cases Controls
1 Ancestral 0.667 0.672
2 Q270 0.059 0.034
3 T606, S610 0.206 0.250
4 L362 -a -
5 Q270, L362 0.005 0.020
6 G671 0.064 0.025
7 F701 - -
aNot detected
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Table 3. Pearson’s chi-squared analysis of EPAS1 diplotypes among cases 
and controls.
EPAS1 diplotypea
1,1 1,2 1,3 1,6
Disease status Obs. Χ2 Obs. Χ2 Obs. Χ2 Obs. Χ2 Totals
Affected 43 0.05 11 0.67 30 0.34 8 1.07 92
Unaffected 45 0.05 6 0.69 36 0.35 3 1.09 90
Totalsb 88 17 66 11 182
aDiplotypes not shown had less than ten total observations and thus were omitted from the 
analysis.
bThe chi-square statistic was 4.3 and the p-value was 0.23.
Table 4. McNemar’s test with EPAS1 T606/S610 
and Q270 variants.
Risk factor presenta
Matched pairsb T606/S610 Q270
Case (1), Control (0) 19 pairs 10 pairs
Case (0), Control (1) 26 pairs 5 pairs
Odds ratio 0.73 2.0
p-value 0.37c 0.30c
95% CI 0.38 - 1.4 0.62 - 7.4
aThe risk factor was defined as having one or two copies 
of the EPAS1 variant.
bThe ‘(1)’ and ‘(0)’ indicate the presence or absence of 
the risk factor, respectively.
cThe p-value is the probability of observing this 
distribution of discordant pairs if there was no 
association between risk factor and disease.
discordant pairs having the T606/S610 variant, the sample size of 
102 pairs achieved 80% power to detect an odds ratio of 2.5 using a 
two-sided McNemar test with a significance level of 0.05. 
Frequencies of three other EPAS1 haplotype variants (Q270, L362, 
and G671) were less than 0.05 and too rare to analyze with a 
McNemar test. Thus, an association with EPAS1 haplotype 
variants was not detected with BCHF in these cattle.
Discussion
The present report describes a set of 102 clinical cases of 
BCHF and their matched controls collected from U.S. feed-
lots where outbreaks were severe and ongoing. Genetic analyses 
of EPAS1 variants did not show an association with BCHF. This 
result was significant because cases were closely matched with 
unaffected penmate controls from the same source, sex, breed 
type, arrival date, and management conditions. In some pairs, 
ear tag information suggested that animals shared the same sire. 
Case-control studies are a common and efficient means of 
studying diseases with a low prevalence and the McNemar’s 
test is the appropriate statistical test for use on paired nominal 
data15. A major advantage of the present design was the abil-
ity to increase the frequency of a potential genetic risk factor 
with relatively few participants (102 cases), while still evalu-
ating more than 10,000 animals per feedlot site for disease. 
Nevertheless, results presented here suggest it is unlikely that 
genetic variation at the EPAS1 locus was a significant genetic risk 
factor for BCHF in these cattle.
The lack of EPAS1 association with BCHF is inconsist-
ent with that reported in 2015 by Newman et al. for cattle with 
high-altitude pulmonary hypertension8. However, there were 
important differences in the cattle types, age, environment, and 
clinical definitions between the two studies. Animals in the 2015 
study were mature, pastured cattle, maintained at 1,478 to 2,618 m, 
and had pulmonary arterial hypertension, as measured by heart 
catheterization. In the present study, animals were yearling steers 
and heifers, raised and fattened at approximately 1,200 m, and had 
end-stage heart failure. Thus, it is possible that the animals 
in these respective studies are suffering from similar but different 
diseases. Another possibility is the cattle described by Newman 
et al. were affected by a right-sided ventricular heart failure ini-
tiated by hypobaric hypoxia, whereas the cattle in the present 
study had a left-sided ventricular failure, resulting in tissue 
hypoxia and subsequent BCHF. The latter was reported in 2019 
in cattle fattened at 1,200 m suffering end-stage heart failure6. 
However, it is unknown whether the disease pathogenesis was a 
distinguishing factor in these studies. One remarkable feature of 
the BCHF clinical cases in the present study were those display-
ing signs of the disease at feedlot arrival and soon after. This is 
consistent with the hypothesis that fattening is not the 
underlying cause of disease in these cattle.
Conclusions
Protein variants encoded by EPAS1 haplotypes were not 
significantly associated with BCHF in fattened cattle at moder-
ate altitudes in the North American Western Plains. Thus, identi-
fying the genetic risk factors underlying this form of the disease 
may require a wider search.
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Data availability
Underlying data
Figshare: Table S1. Metadata and phased EPAS1 diplotypes 
for 102 case-control pairs. https://doi.org/10.6084/m9.figshare. 
8862089.v116 
Extended data
Figshare: Table S2. Summary of 36 possible EPAS1 diplotypes 
and their frequency in cases and controls. https://doi.org/10.6084/
m9.figshare.8862152.v117 
Figshare: Table S3. EPAS1 haplotype frequencies in cases and 
controls. https://doi.org/10.6084/m9.figshare.8862179.v118 
Figshare: Table S4. EPAS1 risk factor scoring used in 
McNemar’s Test with 102 matched pairs. https://doi.org/10.6084/
m9.figshare.8862200.v119 
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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"underlying data" if necessary? This is particularly important because as the authors suggest the
samples and information from these cattle are themselves a very useful resource for studying the
disease, and knowing exactly which samples have been collected might reduce the chance of
duplicated effort in the future.
 
Technically I believe the results section of this manuscript is sound. The methodology for
genotyping using a custom iPLEX gold genotyping array for the six EPAS1 missense SNPs has
been evaluated in previous studies by the authors and to the best of my knowledge the statistical
tests used to analyse the results have been interpreted accurately. 
 
In the discussion the authors mention “In some pairs, ear tag information suggested that animals
shared the same sire.” What was the proportion of the total number of animals that shared the
same sire? Is it possible to determine how many different sires produced the 102 cases and
matched pairs? Were any animals included in the study twins? I am not sure of the twinning rate in
these cattle, I assume it might be quite low, but are there ever cases where one twin is affected by
BCHF and the other unaffected?
 
The lack of an association with the  haplotype variants and BCHF, in the feed lot cattleEPAS1 
raised at moderate altitude included in this study, is a negative but nevertheless important result,
that will be informative to producers, given the importance of BCHF. 
 
This is a well-designed and executed study that has been presented clearly and informatively by
the authors.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
Page 10 of 12
F1000Research 2019, 8:1189 Last updated: 05 SEP 2019
 If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Transcriptomics, ruminants, functional genomics, FAANG, gene expression,
livestock
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
 27 August 2019Reviewer Report
https://doi.org/10.5256/f1000research.21898.r52928
© 2019 Berry D. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution Licence
work is properly cited.
 Donagh P. Berry
Animal and Grassland Research and Innovation Centre, Teagasc, Fermoy, Ireland
The report is extremely well written and of high quality; crucially important that "negative results" are still
published. In the abstract please clarify that the n=102 is 102 pairs - it a bit ambiguous. it would have been
nice to genotype the animals on some for of SNP chip to determine the breed composition (you allude to
not knowing) and also the pedigree structure (may influence your analysis). Other than for breeding
purposes (end of the introduction) the results of such an approach can be used for personalised
management (including purchasing). please re-write the 7th line of the second paragraph in the M&M; i
can't understand what is being said - maybe there is a missing word or two
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Page 11 of 12
F1000Research 2019, 8:1189 Last updated: 05 SEP 2019
 Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: genetic, genomics
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard.
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact   research@f1000.com
Page 12 of 12
F1000Research 2019, 8:1189 Last updated: 05 SEP 2019
